Over the last three years, we have deployed more than ₹2,000 Crore to build world-class manufacturing capabilities. With this major investment cycle reaching completion, we are focussing on scaling newly-created platforms and unlocking returns from strategic initiatives.

These investments have strengthened our foundation for the future, enabling us to accelerate opportunities across high-growth areas, including CDMO, Specialty Chemicals, Nutrition, Personal Care, and Semiconductor applications.